nifedipine has been researched along with aranidipine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haruno, A; Kanda, A; Miyake, H; Nagasaka, M | 1 |
| Ichihara, K; Mori, H; Nagasaka, M; Okumura, K | 1 |
| Kanda, A; Miyake, H; Miyoshi, K; Nakano, M; Nozawa, Y | 1 |
| Kimura, R; Miyake, H; Nozawa, Y; Ohkura, T; Uchida, S; Yamada, S | 1 |
| Ichihara, K; Kamei, H; Miyake, H; Miyoshi, K; Nagasaka, M | 1 |
| Ichihara, K; Kamei, H; Kanda, A; Kanno, T; Miyake, H; Miyoshi, K; Nagasaka, M; Okumura, K | 1 |
6 other study(ies) available for nifedipine and aranidipine
| Article | Year |
|---|---|
Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Dogs; Heart Rate; Hypertension; Hypertension, Renal; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Wistar | 1992 |
Effects of MPC-1304, a novel Ca2+ entry blocker, on alpha-adrenoceptor-mediated pressor responses in pithed rats.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Blood Pressure; Brimonidine Tartrate; Calcium Channel Blockers; Decerebrate State; Dihydropyridines; Electric Stimulation; Nifedipine; Norepinephrine; Phenylephrine; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Spinal Cord; Sympathetic Nervous System | 1993 |
Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Hypertension; Male; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Aorta; Binding, Competitive; Calcium Channel Blockers; Cerebral Cortex; Dihydropyridines; Heart; Hypertension; Male; Nifedipine; Rats; Rats, Inbred SHR; Time Factors | 1995 |
Contribution of aranidipine metabolites with slow binding kinetics to the vasodilating activity of aranidipine.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Dihydropyridines; Dogs; Female; Guinea Pigs; Kinetics; Male; Nifedipine; Regional Blood Flow; Vasodilator Agents | 1997 |
Renal effects of the calcium channel blocker aranidipine and its active metabolite in anesthetized dogs and conscious spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Calcium Channel Blockers; Creatinine; Dihydropyridines; Diuretics; Dogs; Dose-Response Relationship, Drug; Drug Tolerance; Glomerular Filtration Rate; Hemodynamics; Hypertension; Infusions, Intra-Arterial; Kidney; Male; Nifedipine; Organ Size; p-Aminohippuric Acid; Potassium; Rats; Rats, Inbred SHR; Renal Circulation; Sodium; Time Factors; Trichlormethiazide; Urine | 1998 |